✦ LIBER ✦

Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease

✍ Scribed by R.G. MacKenzie; E. Franssen; R. Wong; C. Sawka; N. Berinstein; D.H. Cowan; J. Senn; P. Poldre

Book ID: 111720100
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 203 KB
Volume: 12
Category: Article
ISSN: 1433-2981
DOI: 10.1053/clon.2000.9174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk-Adapted Therapy for Clinical Stage

Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease

✍ R.G. MacKenzie; E. Franssen; R. Wong; C. Sawka; N. Berinstein; D.H. Cowan; J. Se 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Timing of biochemical failure and distan

Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy

✍ Peter B. Morgan; Alexandra L. Hanlon; Eric M. Horwitz; Mark K. Buyyounouski; Rob 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

## Abstract ## BACKGROUND. The relation of prostate cancer risk‐group stratification and the timing of biochemical failure (BF) and distant metastasis (DM) is not well defined. The authors hypothesized that early failures due to subclinical micrometastasis at presentation could be differentiated f

High-dose chemo/radiotherapy and autolog

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission

✍ Auayporn Nademanee; Arturo Molina; Henry Fung; Anthony Stein; Pablo Parker; Ina 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 82 KB

77 Combination of radiotherapy and chemo

77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’

✍ EM Noordijk; P Carde; A Hagenbeek; A-M Mandard; JC Kluin-Nelemans; J Thomas; U T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Five-year Results of Disease Control and

Five-year Results of Disease Control and Quality of Life Analysis of a Combined Hypofractionated Radiation and Hormone Therapy Regimen for Intermediate-risk Prostate Cancer

✍ A. Roux; M. Yassa; C. Lambert; B. Fortin; M. Audet-Lapointe; I. Drapeau; J. Baha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

7033 Five-year results of disease contro

7033 Five-year results of disease control and quality of life analysis of a combined hypofractionated radiation and hormone therapy regimen for intermediate-risk prostate cancer

✍ Roux, A.; Yassa, M.; Lambert, C.; Fortin, B.; Audet-Lapointe, M.; Drapeau, I.; B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB